Author:
Farooqi Ammad Ahmad,Sohail Rubina,Fayyaz Sundas,Shatynska-Mytsyk Iryna
Publisher
Springer International Publishing
Reference30 articles.
1. Azzoli CG, Miller VA, Ng KK, Krug LM, Spriggs DR, Tong WP, Riedel ER, Kris MG (2003) A phase I trial of perillyl alcohol in patients with advanced solid tumors. Cancer Chemother Pharmacol 51(6):493–498
2. Bailey HH, Levy D, Harris LS, Schink JC, Foss F, Beatty P, Wadler S (2002) A phase II trial of daily perillyl alcohol in patients with advanced ovarian cancer: Eastern cooperative oncology group study E2E96. Gynecol Oncol 85(3):464–468
3. Bailey HH, Attia S, Love RR, Fass T, Chappell R, Tutsch K, Harris L, Jumonville A, Hansen R, Shapiro GR, Stewart JA (2008) Phase II trial of daily oral perillyl alcohol (NSC 641066) in treatment-refractory metastatic breast cancer. Cancer Chemother Pharmacol 62(1):149–157
4. Cheng JH, Chang G, Wu WY (2001) A controlled clinical study between hepatic arterial infusion with embolized curcuma aromatic oil and chemical drugs in treating primary liver cancer. Zhongguo Zhong Xi Yi Jie He Za Zhi 21(3):165–167
5. Crowell PL, Elson CE, Bailey HH, Elegbede A, Haag JD, Gould MN (1994) Human metabolism of the experimental cancer therapeutic agent d-limonene. Cancer Chemother Pharmacol 35(1):31–37
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献